Inclusion Criteria:  total insulin daily dose ≥ 8 units HbA1c < 10% capability to use pump and the CGM time from diabetes diagnosis more than 6 months  Exclusion Criteria:  hemophilia or any other bleeding disorder, a condition, which in the opinion of the investigator would put the participant at risk during the trial